The AANZHPBA Conference Committee is inviting abstract submissions for oral, poster or video presentations to be delivered at our ASC in the beautiful Double Bay in Sydney, Australia!
Closing dates: 1st round 25 Jul, 2nd round 15 Aug
https://t.co/638UL9mSAs
SR/MA of total panc vs PD in high-risk POPF patients
6 studies, n=334 TP vs 373 PD
90 day mortality 6.3 vs 6.2%
Major morbidity 29.0% vs. 36.9%; RR=0.73 [95%CI 0.48-1.10]
Comparable LT QOL after TP
https://t.co/4fLvAkX8ri
Simple things. A nice reminder to trainees (and consultants alike) of why we harp on about staying above Rouviere's sulcus in laparoscopic cholecystectomy.
Value of Intraop Ultrasound during surgery for BRPC/LAPC #PancreaticCancer following mostly #FOLFIRINOX?
#ULTRAPANC multic. study🇳🇱: IOUS changed resectability status in 32/85 (38%) pts. In 20/28 (71%) pts w/ presumed SMA involvement,
IOUS found it free
https://t.co/8lqv15qZaO
Applications invited:
💥Kenneth Warren Fellowship💥
2023-24
TWO fellowships of $50,000 each for collaborative research in #HPB diseases in a host department outside the applicant’s own department and country.
👉To apply:
https://t.co/yLBx5e4m88
Closing date: 28 April 2023
Please participate in a 20-question, under-10-minute survey assessing global awareness, perceptions, practice & impediments to enhanced recovery after surgery (#ERAS) in peri-operative care of patients undergoing #pancreatoduodenectomy.
🔗https://t.co/KSxD6c2pIH
@sgeorgebarreto
Join the AGITG’s 24th ASM to discuss emerging research concepts, trial developments, and participate in diverse panel discussions with an internationally renowned faculty @GICancer #AGITG#ASM2022
14-17 Nov 2022 in Melbourne, Australia
https://t.co/eTTLS0Ge2o